Actualités

US FDA's top vaccine official Vinay Prasad leaves agency after 3 months
The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...
Controversial vaccine official Dr. Vinay Prasad departs FDA
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...
Fierce Pharma4 j
Vinay Prasad departs FDA amid conservative criticism, controversy over Sarepta gene therapy
Vinay Prasad, M.D., has left the FDA less than three months into the role as director of the Center for Biologics Evaluation ...
PharmExec3 j
Vinay Prasad’s FDA Departure Follows Controversy Over Drug Rejections
The FDA’s top vaccine and gene therapy official resigned amid heightened scrutiny over recent drug approval decisions and ...
BioPharma Dive4 j
Vinay Prasad, controversial FDA official, abruptly departs agency
Prasad's exit ends a tumultuous tenure during which he led a reworking of agency guidelines on COVID vaccines and his office ...
pharmaphorum4 j
Vinay Prasad abruptly departs from the FDA
Vinay Prasad has stepped down as head of the FDA's Center for Biologics Evaluation and Research (CBER), less than three ...
Vinay Prasad resigns as US FDA Biologics Director after less than 3 months
Prasad, an oncologist who previously criticised the FDA and was a fierce critic of US Covid-19 vaccine and mask mandates, had ...
Fierce Pharma3 j
Vinay Prasad's exit signals FDA's probable slip toward more permissive regulation of cell and gene therapy: analyst
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
STAT4 j
Vinay Prasad, a powerful FDA official, departs after controversy over rare disease drug
Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial ...
US FDA Vaccine Chief Vinay Prasad Leaves Agency 3 Months After Appointment
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...
STAT2 jOpinion
Vinay Prasad is my former student and friend. His departure from FDA is a loss for American medicine
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
Vinay Prasad, High-Risk Drugs and the FDA
U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.